TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2025-03-04
余忠仁Yu, Chong-Jen
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
發表文獻
116筆
81
Tseng FY, Chang YT, Yu CJ, Chang SC. Advanced physical examination training course improves medical students' confidence in physical examination. J Formos Med Assoc. 2019 Oct;118(10):1416-1422. doi: 10.1016/j.jfma.2018.12.013. Epub 2019 Jan 3. PMID: 30612884.
82
Chang LC, Lim CK, Chang LY, Chen KY, Shih JY, Yu CJ. Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors. Eur J Cancer. 2019 Sep;119:77-86. doi: 10.1016/j.ejca.2019.06.025. Epub 2019 Aug 16. PMID: 31425965.
83
Hsiue EH, Lee PL, Chen YH, Yu CJ. Author reply to Letter to Editor "Weaning outcome of solid cancer patients requiring mechanical ventilation in the ICU: Other factors to explore". J Formos Med Assoc. 2019 Dec;118(12):1678-1679. doi: 10.1016/j.jfma.2019.09.002. Epub 2019 Sep 17. PMID: 31540816.
84
Huang CT, Tsai YJ, Ho CC, Yu CJ. Radial endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary malignancy: biopsy- or brushing-first? BMC Pulm Med. 2019 Oct 31;19(1):193. doi: 10.1186/s12890-019-0961-0. PMID: 31672128; PMCID: PMC6823946.
85
Huang CT, Lee MR, Ruan SY, Tsai YJ, Wang JY, Yu CJ. Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis. Respir Med. 2019 Oct-Nov;158:49-54. doi: 10.1016/j.rmed.2019.10.004. Epub 2019 Oct 7. PMID: 31605921.
86
Lin FL, Yeh ML, Lai YH, Lin KC, Yu CJ, Chang JS. Two-month breathing-based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study. J Clin Nurs. 2019 Oct;28(19-20):3632-3640. doi: 10.1111/jocn.14960. Epub 2019 Jun 28. PMID: 31192478.
87
Lee JH, Chen HY, Hsu FM, Chen JS, Liao WY, Shih JY, Yu CJ, Chen KY, Tsai TH, Yang JC. Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors. Oncologist. 2019 Dec;24(12):e1417-e1425. doi: 10.1634/theoncologist.2019-0152. Epub 2019 May 24. PMID: 31127020; PMCID: PMC6975931.
88
Yao ZH, Liao WY, Ho CC, Chen KY, Shih JY, Chen JS, Lin ZZ, Lin CC, Yang JC, Yu CJ. Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients. Eur J Cancer. 2019 Aug;117:107-115. doi: 10.1016/j.ejca.2019.05.032. Epub 2019 Jul 3. PMID: 31279301.
89
Wu MF, Shu CC, Wang JY, Yan BS, Lai HC, Chiang BL, Wu LS, Yu CJ. NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility. Sci Rep. 2019 Aug 29;9(1):12534. doi: 10.1038/s41598-019-47609-3. PMID: 31467293; PMCID: PMC6715708.
90
Liu CJ, Lee TF, Ruan SY, Yu CJ, Chien JY, Hsueh PR. Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients. Infect Drug Resist. 2019 May 30;12:1457-1467. doi: 10.2147/IDR.S199761. PMID: 31239724; PMCID: PMC6554003.
